James Brian Windsor is Chief Science Officer of TFF Pharmaceuticals, Inc.. Currently has a direct ownership of 5,000 shares of TFFP, which is worth approximately $300. The most recent transaction as insider was on Dec 07, 2020, when has been sold 25,000 shares (Common Stock) at a price of $15.8 per share, resulting in proceeds of $395,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $300

JAMES BRIAN WINDSOR Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 07 2020
SELL
Open market or private sale
$395,000 $15.8 p/Share
25,000 Reduced 83.33%
5,000 Common Stock
Dec 07 2020
BUY
Exercise of conversion of derivative security
$62,500 $2.5 p/Share
25,000 Added 45.45%
30,000 Common Stock

Also insider at

ALRN
AILERON THERAPEUTICS INC Healthcare
JBW

James Brian Windsor

Chief Science Officer
Austin, TX

Track Institutional and Insider Activities on TFFP

Follow TFF Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TFFP shares.

Notify only if

Insider Trading

Get notified when an Tff Pharmaceuticals, Inc. insider buys or sells TFFP shares.

Notify only if

News

Receive news related to TFF Pharmaceuticals, Inc.

Track Activities on TFFP